Polaris Quantum Biotech Inc Blog Quantum-Aided Drug Design for Inhibiting Protein-Protein Interactions for Emerging Threats

Introduction The DARPA IMPAQT ARC Opportunity solicited ideas to explore the following question: What are the applications for a quantum system with N*q > 10,000 as a co-processor for a classical computational system? DARPA contracted PolarisQB to expand our Quantum-Aided Drug Design (QuADD) for inhibiting protein-protein interactions (PPIs) for emerging threats.